259 related articles for article (PubMed ID: 23532004)
1. Relationship of early-onset baldness to prostate cancer in African-American men.
Zeigler-Johnson C; Morales KH; Spangler E; Chang BL; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):589-96. PubMed ID: 23532004
[TBL] [Abstract][Full Text] [Related]
2. Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
[TBL] [Abstract][Full Text] [Related]
3. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
[TBL] [Abstract][Full Text] [Related]
4. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
Papa NP; MacInnis RJ; English DR; Bolton D; Davis ID; Lawrentschuk N; Millar JL; Severi G; Hopper JL; Giles GG
Cancer Causes Control; 2018 Jan; 29(1):93-102. PubMed ID: 29139043
[TBL] [Abstract][Full Text] [Related]
5. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
6. The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.
Vaarala MH; Mattila H; Ohtonen P; Tammela TL; Paavonen TK; Schleutker J
Int J Cancer; 2008 Jun; 122(11):2511-6. PubMed ID: 18306354
[TBL] [Abstract][Full Text] [Related]
7. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
8. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
[TBL] [Abstract][Full Text] [Related]
9. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.
Makridakis NM; Ross RK; Pike MC; Crocitto LE; Kolonel LN; Pearce CL; Henderson BE; Reichardt JK
Lancet; 1999 Sep; 354(9183):975-8. PubMed ID: 10501358
[TBL] [Abstract][Full Text] [Related]
10. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
[TBL] [Abstract][Full Text] [Related]
11. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
Hawk E; Breslow RA; Graubard BI
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
[TBL] [Abstract][Full Text] [Related]
12. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
[TBL] [Abstract][Full Text] [Related]
13. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
[TBL] [Abstract][Full Text] [Related]
14. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
16. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
17. Smoking and prostate cancer in a multi-ethnic cohort.
Murphy AB; Akereyeni F; Nyame YA; Guy MC; Martin IK; Hollowell CM; Walker K; Kittles RA; Ahaghotu C
Prostate; 2013 Oct; 73(14):1518-28. PubMed ID: 23824512
[TBL] [Abstract][Full Text] [Related]
18. Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.
Khan S; Caldwell J; Wilson KM; Gonzalez-Feliciano AG; Peisch S; Pernar CH; Graff RE; Giovannucci EL; Mucci LA; Gerke TA; Markt SC
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1229-1236. PubMed ID: 32277004
[TBL] [Abstract][Full Text] [Related]
19. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
20. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
